A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois

• DOI: 10.1089/apc.2020.0103
• Publication Date: 2020-05-29T16:04:56Z
• Authors: Jessica P. Ridgway; Brianna Farley; Jean-Luc Benoit; Christopher Frohne; Aniruddha Hazra; Natasha Pettit; Mai Pho; Kenneth Pursell; Jina Saltzman; Jessica Schmitt; Arno Ziggy Uvin; David Pitrak; Moira McNulty
• Keywords: Hydroxychloroquine; Demographics

The risk of COVID-19 among people living with HIV (PLWH) is largely unknown and there have been very few reported cases in the literature. We report a case series five PLWH COVID-19. identified all patients diagnosis who tested positive for SARS-CoV-2 at University Chicago Medicine between March 1, 2020, April 7, 2020. retrospectively collected data regarding demographics, comorbidities, medications, laboratory test results, radiology outcomes associated All were African American; 80% (4/5) cisgender females. mean age was 48 years old (range 38–53). majority presented cough, fever, shortness breath. Three had diarrhea. One patient predominantly cardiac symptoms. taking antiretroviral therapy (ART) CD4 count >200 cells/mm3 suppressed viral loads time diagnosis. hospitalized, two required supplemental oxygen, none mechanical ventilation. Four treated azithromycin cephalosporin also hydroxychloroquine. median length stay 3 days 2–7). recovered. More research needed to understand risks impact ART on